Dicloxacillin is indicated for the treatment of infections caused by penicillin-resistant but dicloxacillin-susceptible staphylococci, including sepsis, endocarditis, respiratory tract infections, and skin and soft tissue infections. It may also be used for mixed infections caused by penicillin-resistant staphylococci together with Streptococcus pyogenes or Streptococcus pneumoniae. However, it is not effective against methicillin-resistant Staphylococcus aureus (MRSA) infections.